What class of drugs does dexmethylphenidate (Azstarys) belong to?

Dexmethylphenidate (Azstarys) is a central nervous system stimulant drug, which is mainly used to treat attention deficithyperactivity disorder (ADHD). ADHD is a common neurodevelopmental disorder, mainly characterized by inattention, hyperactivity and impulsive behavior. Such symptoms will have a significant impact on the learning, social and living abilities of children and adolescents. The pharmacological mechanism of Azstarys involves increasing the activity of dopamine and norepinephrine in the brain, thereby improving nerve signal transmission, allowing patients to increase their concentration and reduce impulsive behavior.

In terms of drug classification,Azstarys is similar to traditional central nervous system stimulants, including methylphenidates and dexmethylphenidate derivatives. Compared with other ADHD drugs, Azstarys uses a dosage form that combines sustained release and immediate release, which allows the drug to be released smoothly, reducing side effects caused by fluctuations in blood concentration, while improving concentration and behavioral control during the day. This design can not only reduce patients' hyperactive impulsivity, but also improve executive functions, making patients more focused in learning and daily life.

Currently,Azstarys has been approved in overseas markets for ADHD patients aged 6 years and above, but has not yet been officially launched in mainland China. Its research and development background and clinical trial data show that the drug has certain advantages in terms of safety and effectiveness, especially in long-term treatment, and is well tolerated. This also provides parents and doctors with more treatment options to improve academic and social development in children and adolescents.

In summary, dexmethylphenidate (Azstarys) is a central nervous system stimulant drug. It is a prescription drug specially designed to treat ADHD symptoms and is suitable for children and adolescents aged 6 years and above. It improves attention and behavioral control by regulating neurotransmitter activity and is one of the more advanced drug options in current ADHD treatment.

Reference materials:https://azstarys.com/